Gastro-intestinal biomarkers for diagnosis and therapies of proteinopathies

Pharmaceutical composition for the treatment of proteinopathies comprising products which are able to stimulate growth or inhibition of at least one of Odoribacter, Oscillospira, Dehalobacterium, Alistipes, Parabacteroides, Lactobacillus and Sutterella, Firmicutes, Bacteroidetes, Allobaculum and Akkermansia bacteria population in the gut of individuals.


Year:
2016
Other identifiers:
EPO Family ID: 55361909
TTO: 6.1465
Laboratories:




 Record created 2017-05-11, last modified 2018-09-13


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)